Naphthylaminopropane

Naphthylaminopropane (NAP; code name PAL-287), also known as naphthylisopropylamine (NIPA), is an experimental drug of the amphetamine and naphthylaminopropane families that was under investigation for the treatment of alcohol and stimulant addiction. == Pharmacology == === Pharmacodynamics === ==== Activities ==== Naphthylaminopropane is a serotonin–norepinephrine–dopamine releasing agent (SNDRA).

Source: Wikipedia — Naphthylaminopropane (CC BY-SA 4.0)

Naphthylaminopropane

Naphthylaminopropane (NAP; code name PAL-287), also known as naphthylisopropylamine (NIPA), is an experimental drug of the amphetamine and naphthylaminopropane families that was under investigation for the treatment of alcohol and stimulant addiction. == Pharmacology == === Pharmacodynamics === ==== Activities ==== Naphthylaminopropane is a serotonin–norepinephrine–dopamine releasing agent (SNDRA).

Source: Wikipedia "Naphthylaminopropane" · CC BY-SA 4.0

Share this article: X · Bluesky
Privacy Policy